| A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma | 2015-05-20 | 2023-06-02 | |
| A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease | 2021-03-03 | 2023-05-24 | |
| A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions | 2020-10-13 | 2023-05-03 | 2024-05-01 |
| A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant | 2020-09-16 | 2023-04-25 | |
| Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide | 2017-10-05 | 2023-03-31 | 2024-03-24 |
| A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis | 2022-06-13 | 2023-03-23 | |
| A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed | 2019-07-18 | 2023-02-17 | 2024-02-16 |
| A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection | 2021-03-11 | 2023-02-08 | 2024-02-08 |
| A Study of Guselkumab in Participants With Active Lupus Nephritis | 2020-09-15 | 2023-02-01 | 2024-02-01 |
| A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis | 2022-02-03 | 2022-12-15 | |
| A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma | 2022-10-20 | 2022-11-15 | |
| Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab | 2019-05-31 | 2022-10-24 | 2023-10-12 |
| A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder | 2018-11-07 | 2022-10-17 | |
| A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa | 2021-10-12 | 2022-10-14 | 2023-10-12 |
| A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever | 2022-01-24 | 2022-09-24 | 2024-02-05 |
| A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | 2018-05-14 | 2022-09-22 | 2023-09-20 |
| A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis | 2021-10-14 | 2022-08-10 | |
| A Study of JNJ-64304500 in Participants With Alopecia Areata | 2021-03-24 | 2022-06-02 | |
| A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection | 2020-08-13 | 2022-06-01 | 2023-06-01 |
| A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy | 2020-09-15 | 2022-05-24 | |
| A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection | 2021-02-01 | 2022-05-16 | |
| A Study of Paliperidone Palmitate 6-Month Formulation | 2019-09-19 | 2022-05-03 | 2023-05-03 |
| Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection | 2018-11-29 | 2022-04-18 | 2023-04-11 |
| A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection | 2021-11-17 | 2022-03-31 | 2023-03-30 |
| A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) | 2021-09-06 | 2022-03-18 | 2023-03-16 |
| A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis | 2021-09-02 | 2022-03-09 | 2023-03-08 |
| A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis | 2021-05-03 | 2022-02-02 | 2023-02-01 |
| A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection | 2021-11-03 | 2021-12-29 | 2024-02-08 |
| A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease | 2019-09-23 | 2021-11-17 | 2022-11-11 |
| A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure | 2020-03-10 | 2021-11-09 | 2022-11-07 |
| A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer | 2019-01-25 | 2021-10-08 | 2023-09-08 |
| A Study of JNJ-61393215 in the Treatment of Depression | 2019-09-17 | 2021-09-02 | 2022-09-02 |
| A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease | 2019-10-10 | 2021-05-15 | 2022-05-12 |
| A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression | 2018-05-25 | 2021-04-13 | 2022-04-12 |
| A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery | 2019-06-17 | 2021-04-06 | 2022-04-06 |
| A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | 2018-04-17 | 2021-02-26 | 2022-02-25 |
| An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies | 2016-08-31 | 2021-01-26 | 2022-01-25 |
| Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease | 2016-08-25 | 2020-12-10 | 2021-12-10 |
| A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | 2018-11-20 | 2020-12-01 | 2023-11-17 |
| A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus | 2018-04-16 | 2020-11-05 | 2021-11-03 |
| A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens | 2018-04-26 | 2020-08-12 | 2021-12-16 |
| A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis | 2019-10-16 | 2020-06-30 | 2023-06-28 |
| A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications | 2018-01-21 | 2020-05-28 | 2021-04-30 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) | 2018-09-04 | 2020-05-22 | 2021-05-18 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa | 2019-09-16 | 2020-05-19 | 2023-05-17 |
| A Study of Paliperidone Palmitate 6-Month Formulation | 2017-11-20 | 2020-05-08 | 2021-09-22 |
| A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression | 2018-07-16 | 2020-05-06 | 2023-05-02 |
| A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection | 2018-01-03 | 2020-03-31 | 2021-03-19 |
| A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis | 2017-10-05 | 2020-02-14 | 2021-02-11 |
| A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus | 2018-02-06 | 2019-11-27 | 2022-05-13 |